Protocol No.: CS15IONIS

CS15: An Open-Label Extension Study of Olezarsen (ISIS 678354) Administered Subcutaneously to Patients With Severe Hypertriglyceridemia (SHTG)
Principal Investigator
Morise, Anthony
Phase
III
Age Group
Adult
Applicable Disease Site
Other
Participating Institutions
Heart & Vascular Institute
West Virginia University
Contacts
Tanja Aucremanne
Study Coordinator
Joshua Bombard, MS
Research Specialist
Phone: +1 304-598-4000 ext. 76424

View on ClinicalTrials.gov